LGALS9 and hepatocellular carcinoma: The background for the enhancement of galectin-9 expression in HCC cells by interferon is that galectin-9 is a target of microRNA 22 (miR-22), and restoring galectin-9 expression in miR-22 overexpressing cells enhanced its antitumor effect [104].